These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 3839808)

  • 1. A comparative evaluation of levamisole in leprosy.
    Sharma L; Thalliath GH; Girgia HS; Sen PC
    Indian J Lepr; 1985; 57(1):11-6. PubMed ID: 3839808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY; Wallach D; Spindler E; Pennec J; Cottenot F; Flageul B
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of levamisole on clinical outcome and DNCB conversion in leprosy patients. A long term study.
    Yagnik CS; Jogaikar DG; Mehta JM
    Lepr India; 1983 Jan; 55(1):68-70. PubMed ID: 6680021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the administration of B663 [G 30 320, Lamprene, clofazimine (Geigy)] on three groups of lepromatous and borderline of leprosy.
    Rodriguez JN; Abalos RM; Reich CV; Tolentino JG
    Int J Lepr Other Mycobact Dis; 1974; 42(3):276-88. PubMed ID: 4617715
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled long-term therapy of leprosy with B663 (lamprene, clofazimine) compared with DDS.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1974; 42(4):416-418. PubMed ID: 4617720
    [No Abstract]   [Full Text] [Related]  

  • 6. Clofazimine in lepra (ENL) reaction, one year clinical trial.
    Burte NP; Chandorkar AG; Muley MP; Balsara JJ; Bulakh PM
    Lepr India; 1983 Apr; 55(2):265-77. PubMed ID: 6355652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo and in vitro effects of levamisole in patients with lepromatous leprosy.
    Sher R; Wadee AA; Joffe M; Kok SH; Imkamp FM; Simson IW
    Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):159-66. PubMed ID: 7196885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical trial with clofazimine in leprosy.
    Ganapati R; Dongre VV
    Lepr India; 1976 Oct; 48(4 Suppl):703-8. PubMed ID: 1026807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple drug therapy--a comparative study with 2 tier and 3 tier combination of rifampicin, clofazimine, DDS, INAH and thiacetazone in lepromatous cases.
    Kundu SK; Ghosh S; Hazra S; Chaudhury S
    Lepr India; 1981 Apr; 53(2):248-58. PubMed ID: 6166791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral zinc in recurrent Erythema Nodosum Leprosum reaction.
    Mathur NK; Bumb RA; Mangal HN
    Lepr India; 1983 Jul; 55(3):547-52. PubMed ID: 6656212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of steroid dependant cases of recurrent lepra reaction with a combination of thalidomide and clofazimine.
    Ramu G; Girdhar A
    Lepr India; 1979 Oct; 51(4):497-504. PubMed ID: 522443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multidrug therapy in hospitalised leprosy cases.
    Tiwari VD; Tutakne MA; Singh G; Dutta RK
    Indian J Lepr; 1988 Jan; 60(1):71-6. PubMed ID: 3204277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study on the relationship between intensive bactericidal therapy and leprosy reactions.
    Groenen G; Janssens L; Kayembe T; Nollet E; Coussens L; Pattyn SR
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):236-44. PubMed ID: 3722962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of drug treatment on electroneurological measures of peripheral nerve function in leprosy patients.
    Mendis S; Somasiri KG; Chularatna W
    Ceylon Med J; 1993 Dec; 38(4):174-7. PubMed ID: 8143332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of clofazimine in the treatment of lepra reactions.
    Mishra B; Girdhar BK
    Indian J Lepr; 1986; 58(1):73-8. PubMed ID: 3746000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation from lepromatous to borderline leprosy under clofazimine therapy.
    Mahapatra SB; Ramu G
    Lepr India; 1976 Apr; 48(2):172-6. PubMed ID: 1022964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levamisole in cases of E.N.L.
    Arora SK; Singh G; Sen PC
    Indian J Lepr; 1985; 57(1):17-21. PubMed ID: 3897404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Present evaluation of hansenian treatment by association of chemotherapy and immunostimulation (author's transl)].
    Saint-Andre P; Louvet M; Giraudeau P; Discamps G; Schlecht B
    Med Trop (Mars); 1978; 38(3):331-49. PubMed ID: 723581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.